Highly bioavailable curcumin from CAVACURMIN® empowers your formulation with unique advantages: 40 times better absorption than pure curcumin products and easy formulation into shots, capsules and tablets. Read the clinical human study on the exceptional bioavailability of CAVACURMIN® – published by the European Journal of Nutrition.
Wacker Chemie AG
Tel. +49 89 6279-1346
Fax. +49 89 6279-2507
WACKER BIOSOLUTIONS, WACKER’s life science and biotechnology division, offers a broad range of innovative tailored products and solutions for the life science sector – particularly for the functional food and nutraceutical industries.
These include CAVAMAX® W6 alpha-cyclodextrin, a natural, starch-derived oligosaccharide. It can be added as a fully fermentable dietary fiber to foods and beverages, including carbonated and non-carbonated transparent soft drinks. CAVAMAX® W6 is scientifically proven to significantly reduce the post-prandial glycaemic response – an effect officially acknowledged by EFSA. Besides, it interacts with triglycerides building up a surfactant-like structure that stabilizes oil-in-water emulsions efficiently. With CAVAMAX® W6, WACKER thus offers manufacturers a possibility to replace emulsifiers with a soluble fiber.
Furthermore, WACKER offers molecular encapsulation solutions based on our cyclodextrin technology for odor or taste-masking, to stabilize food ingredients against heat and oxidation and to increase the bioavailability of functional ingredients. We have over 15 years of experience in manufacturing and formulating alpha-, beta- and gamma-cyclodextrins.
Additionally, WACKER produces a high-quality range of non-human, non-animal derived L-cysteine products. WACKER is the world’s only manufacturer of vegetarian-grade cysteine using a patented biotech process.
12 May 2017 --- One of the standout trends at Vitafoods 2017 was the rise of products featuring turmeric and its derivative, curcumin. “The market for turmeric is blooming,” Alexis Manfre, Nutrition and Health Category Manager at Naturex, tells NutritionInsight. “Turmeric has become the botanical superstar [globally]. If you look at the European market, the recent growth in the last year is 30 to 40%.”
24 Feb 2017 --- A clinical study that was recently published in the European Journal of Nutrition shows that the bioavailability of curcumin can be increased significantly with the help of gammadextrin – by a factor of 40 compared to conventional curcumin extract.
26 June 2013 --- The European Commission has verified a health claim for alpha-cyclodextrin. The EU assessment report confirms that alpha-cyclodextrin can reduce blood sugar peaks following a high-starch meal.